BONE RESORPTION TEST ABNORMAL

This adverse event was reported 31 times

These drugs are most commonly taken by patients reporting BONE RESORPTION TEST ABNORMAL:

# Drug Count
0 DENOSUMAB 14
1 ALENDRONATE SODIUM 5
2 RISEDRONATE SODIUM 3
3 CALCIUM 2
4 CONJUGATED ESTROGENS 2
5 ESOMEPRAZOLE MAGNESIUM 2
6 ESTROGENS, CONJUGATED 2
7 ADALIMUMAB 1
8 ADALIMUMAB-AATY 1
9 ADALIMUMAB-ADAZ 1
See all common drugs associated with BONE RESORPTION TEST ABNORMAL

BONE RESORPTION TEST ABNORMAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CONJUGATED ESTROGENS/BAZEDOXIFENE 1 0.0011
1 TEPROTUMUMAB 1 0.0002
2 BUROSUMAB 1 0.0002
3 RISEDRONATE SODIUM 3 0.0001
4 DENOSUMAB 14 0.0001
5 INDAPAMIDE 1 0.0001
6 ALENDRONATE SODIUM 5 0.0000
7 TESTOSTERONE 1 0.0000
8 IMATINIB MESYLATE 1 0.0000
9 CONJUGATED ESTROGENS 2 0.0000
See all drugs enriched for association with BONE RESORPTION TEST ABNORMAL

BONE RESORPTION TEST ABNORMAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] 1 0.0002
1 RANK Ligand Inhibitor [EPC] 14 0.0001
2 Androgen [EPC] 1 0.0000
3 Estrogen Receptor Antagonist [EPC] 1 0.0000
4 Thiazide-like Diuretic [EPC] 1 0.0000
5 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
6 Estrogen [EPC] 3 0.0000
7 Calcium [EPC] 2 0.0000
8 Antirheumatic Agent [EPC] 1 0.0000
9 Parathyroid Hormone Analog [EPC] 1 0.0000
See all drug classes enriched for association with BONE RESORPTION TEST ABNORMAL